
### [MONDO:0016797](http://purl.obolibrary.org/obo/MONDO_0016797)
**Label:** multiple mitochondrial DNA deletion syndrome

**Subclasses:** [MONDO:0012241](http://purl.obolibrary.org/obo/MONDO_0012241) (progressive external ophthalmoplegia with mitochondrial Dna deletions, autosomal dominant 3), [MONDO:0016810](http://purl.obolibrary.org/obo/MONDO_0016810) (autosomal recessive progressive external ophthalmoplegia), [MONDO:0014720](http://purl.obolibrary.org/obo/MONDO_0014720) (autosomal dominant optic atrophy plus syndrome), [MONDO:0016798](http://purl.obolibrary.org/obo/MONDO_0016798) (ataxia neuropathy spectrum), [MONDO:0008131](http://purl.obolibrary.org/obo/MONDO_0008131) (optic atrophy, hearing loss, and peripheral neuropathy, autosomal dominant), [MONDO:0009783](http://purl.obolibrary.org/obo/MONDO_0009783) (progressive external ophthalmoplegia with mitochondrial Dna deletions, autosomal recessive 1), [MONDO:0008003](http://purl.obolibrary.org/obo/MONDO_0008003) (autosomal dominant progressive external ophthalmoplegia), [MONDO:0014062](http://purl.obolibrary.org/obo/MONDO_0014062) (mitochondrial DNA deletion syndrome with progressive myopathy), [MONDO:0019791](http://purl.obolibrary.org/obo/MONDO_0019791) (recessive mitochondrial ataxia syndrome), [MONDO:0007429](http://purl.obolibrary.org/obo/MONDO_0007429) (optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy), [MONDO:0016809](http://purl.obolibrary.org/obo/MONDO_0016809) (spinocerebellar ataxia with epilepsy), [MONDO:0012238](http://purl.obolibrary.org/obo/MONDO_0012238) (progressive external ophthalmoplegia with mitochondrial Dna deletions, autosomal dominant 2), [MONDO:0011038](http://purl.obolibrary.org/obo/MONDO_0011038) (cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome), [MONDO:0011835](http://purl.obolibrary.org/obo/MONDO_0011835) (sensory ataxic neuropathy-dysarthria-ophthalmoparesis syndrome), [MONDO:0014898](http://purl.obolibrary.org/obo/MONDO_0014898) (progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 3; PEOB3), [MONDO:0014899](http://purl.obolibrary.org/obo/MONDO_0014899) (adult-onset multiple mitochondrial DNA deletion syndrome due to DGUOK deficiency), [MONDO:0013117](http://purl.obolibrary.org/obo/MONDO_0013117) (progressive external ophthalmoplegia with mitochondrial Dna deletions, autosomal dominant 5), [MONDO:0012415](http://purl.obolibrary.org/obo/MONDO_0012415) (progressive external ophthalmoplegia with mitochondrial Dna deletions, autosomal dominant 4), 

**Corr. equiv. classes:** [OMIM:157640](http://purl.obolibrary.org/obo/OMIM_157640), [Orphanet:254881](http://www.orpha.net/ORDO/Orphanet_254881), [Orphanet:254892](http://www.orpha.net/ORDO/Orphanet_254892), [OMIM:617070](http://purl.obolibrary.org/obo/OMIM_617070), [OMIM:607459](http://purl.obolibrary.org/obo/OMIM_607459), [Orphanet:254886](http://www.orpha.net/ORDO/Orphanet_254886), [Orphanet:1171](http://www.orpha.net/ORDO/Orphanet_1171), [OMIM:601338](http://purl.obolibrary.org/obo/OMIM_601338), [OMIM:617069](http://purl.obolibrary.org/obo/OMIM_617069), [Orphanet:329314](http://www.orpha.net/ORDO/Orphanet_329314), [OMIM:609283](http://purl.obolibrary.org/obo/OMIM_609283), [OMIM:613077](http://purl.obolibrary.org/obo/OMIM_613077), [OMIM:615156](http://purl.obolibrary.org/obo/OMIM_615156), [OMIM:610131](http://purl.obolibrary.org/obo/OMIM_610131), [Orphanet:254818](http://www.orpha.net/ORDO/Orphanet_254818), [OMIM:616648](http://purl.obolibrary.org/obo/OMIM_616648), [Orphanet:352470](http://www.orpha.net/ORDO/Orphanet_352470), [Orphanet:70595](http://www.orpha.net/ORDO/Orphanet_70595), [OMIM:165199](http://purl.obolibrary.org/obo/OMIM_165199), [OMIM:125250](http://purl.obolibrary.org/obo/OMIM_125250), [OMIM:258450](http://purl.obolibrary.org/obo/OMIM_258450), [Orphanet:1215](http://www.orpha.net/ORDO/Orphanet_1215), [Orphanet:94125](http://www.orpha.net/ORDO/Orphanet_94125), [OMIM:609286](http://purl.obolibrary.org/obo/OMIM_609286), 

**Class expressions from DL-Learner:**

- [HP:0000508](http://purl.obolibrary.org/obo/HP_0000508) (Ptosis) and [HP:0000590](http://purl.obolibrary.org/obo/HP_0000590) (Progressive external ophthalmoplegia) and [HP:0003800](http://purl.obolibrary.org/obo/HP_0003800) (Muscle abnormality related to mitochondrial dysfunction) 66.18%
- [HP:0000590](http://purl.obolibrary.org/obo/HP_0000590) (Progressive external ophthalmoplegia) and [HP:0003800](http://purl.obolibrary.org/obo/HP_0003800) (Muscle abnormality related to mitochondrial dysfunction) and [HP:0025270](http://purl.obolibrary.org/obo/HP_0025270) (Abnormality of esophagus physiology) 64.58%
- [HP:0000590](http://purl.obolibrary.org/obo/HP_0000590) (Progressive external ophthalmoplegia) and [HP:0003800](http://purl.obolibrary.org/obo/HP_0003800) (Muscle abnormality related to mitochondrial dysfunction) and [HP:0011446](http://purl.obolibrary.org/obo/HP_0011446) (Abnormality of higher mental function) 64.58%
- [HP:0000590](http://purl.obolibrary.org/obo/HP_0000590) (Progressive external ophthalmoplegia) and [HP:0003581](http://purl.obolibrary.org/obo/HP_0003581) (Adult onset) and [HP:0003800](http://purl.obolibrary.org/obo/HP_0003800) (Muscle abnormality related to mitochondrial dysfunction) 64.58%
- [HP:0000508](http://purl.obolibrary.org/obo/HP_0000508) (Ptosis) and [HP:0000590](http://purl.obolibrary.org/obo/HP_0000590) (Progressive external ophthalmoplegia) and [HP:0003581](http://purl.obolibrary.org/obo/HP_0003581) (Adult onset) 64.58%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0000590](http://purl.obolibrary.org/obo/HP_0000590) (Progressive external ophthalmoplegia) and [HP:0025270](http://purl.obolibrary.org/obo/HP_0025270) (Abnormality of esophagus physiology) 64.58%
- [HP:0000590](http://purl.obolibrary.org/obo/HP_0000590) (Progressive external ophthalmoplegia) and [HP:0003800](http://purl.obolibrary.org/obo/HP_0003800) (Muscle abnormality related to mitochondrial dysfunction) 63.98%
- [HP:0000590](http://purl.obolibrary.org/obo/HP_0000590) (Progressive external ophthalmoplegia) and [HP:0003800](http://purl.obolibrary.org/obo/HP_0003800) (Muscle abnormality related to mitochondrial dysfunction) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) 63.98%
- [HP:0000590](http://purl.obolibrary.org/obo/HP_0000590) (Progressive external ophthalmoplegia) and [HP:0003800](http://purl.obolibrary.org/obo/HP_0003800) (Muscle abnormality related to mitochondrial dysfunction) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) 63.98%
- [HP:0000590](http://purl.obolibrary.org/obo/HP_0000590) (Progressive external ophthalmoplegia) and [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) and [HP:0003800](http://purl.obolibrary.org/obo/HP_0003800) (Muscle abnormality related to mitochondrial dysfunction) 63.98%
- [HP:0000590](http://purl.obolibrary.org/obo/HP_0000590) (Progressive external ophthalmoplegia) and [HP:0040064](http://purl.obolibrary.org/obo/HP_0040064) (Abnormality of limbs) 62.50%
- [HP:0000590](http://purl.obolibrary.org/obo/HP_0000590) (Progressive external ophthalmoplegia) and [HP:0003701](http://purl.obolibrary.org/obo/HP_0003701) (Proximal muscle weakness) 62.50%
- [HP:0000006](http://purl.obolibrary.org/obo/HP_0000006) (Autosomal dominant inheritance) and [HP:0000590](http://purl.obolibrary.org/obo/HP_0000590) (Progressive external ophthalmoplegia) 62.50%
- [HP:0000590](http://purl.obolibrary.org/obo/HP_0000590) (Progressive external ophthalmoplegia) and [HP:0004302](http://purl.obolibrary.org/obo/HP_0004302) (Functional motor problems) and [HP:0009141](http://purl.obolibrary.org/obo/HP_0009141) (Depletion of mitochondrial DNA in muscle tissue) 62.50%
- [HP:0000590](http://purl.obolibrary.org/obo/HP_0000590) (Progressive external ophthalmoplegia) and [HP:0003800](http://purl.obolibrary.org/obo/HP_0003800) (Muscle abnormality related to mitochondrial dysfunction) and [HP:0004302](http://purl.obolibrary.org/obo/HP_0004302) (Functional motor problems) 62.50%


